Thomas v. Novo Nordisk A/S et al
| Donna Lou Thomas and Donna Thomas |
| Novo Nordisk A/S, Novo Nordisk North America Operations A/S, Novo Nordisk U S Holdings Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk Inc, Novo Nordisk Research Center Seattle Inc, Novo Nordisk Pharmaceutical Industries L P and Eli Lilly & Co |
| 6:2023cv01793 |
| December 27, 2023 |
| US District Court for the Western District of Louisiana |
| Robert R Summerhays |
| Carol B Whitehurst |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 Diversity-Product Liability |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 20, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| DISTRICT COURT TRANSFER Record Received electronically by Eastern District of Pennsylvania on 2/20/2024, assigned case number 2:24-cv-00735. (crt,Alexander, E) |
Filing 6
ORDER FOR MULTI-DISTRICT LITIGATION TRANSFER CTO # 1, directing transfer to Eastern District of Pennsylvania, In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL # 3094. Record electronically transmitted to receiving court. Case Terminated. All future pleadings should be filed with the newly assigned court. (crt,Alexander, E)
|
| Filing 5 NOTICE received via email from Clerk of Judicial Panel on Multidistrict Litigation transmitting Conditional Transfer Order (CTO-1) in MDL No.3094, IN RE: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation advising case shall be transferred to the Eastern District of Pennsylvania upon request of the record. (crt,Alexander, E) |
| Filing 4 DIVERSITY JURISDICTION DISCLOSURE STATEMENT by Donna Thomas. (aty,Rocha, Rene) |
| Filing 3 SUMMONS ISSUED as to Eli Lilly & Co, Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (crt,Thomas, T) |
| Filing 2 NOTICE of Diversity Jurisdiction Disclosure Statement Requirement re: #1 Complaint, sent to Rene Fernandez Rocha on behalf of Donna Thomas. Diversity Jurisdiction Disclosure Statement due by 1/17/2024. (crt,Thomas, T) |
| CASE Assigned to Judge Robert R Summerhays and Magistrate Judge Carol B Whitehurst. (crt,Thomas, T) |
| Filing 1 COMPLAINT against Eli Lilly & Co, Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc with Jury Demand (Filing fee $405, receipt number ALAWDC-5803743) filed by Donna Lou Thomas. (Attachments: #1 Civil cover sheet)(Attorney Rene Fernandez Rocha added to party Donna Lou Thomas(pty:pla))(aty,Rocha, Rene) (Attachment 1 modified to nonfillable form and replaced on 1/3/2024) (Thomas, T). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Louisiana Western District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
